Filing Flows › SeaStar Medical Holding (ICU) › Q2 2026 › vs Q2 2025
SeaStar Medical Holding (ICU) Q2 2026 vs Q2 2025 (year over year)
SeaStar Medical Holding's revenue rose $277K (+82%) from $338K in Q2 2025 to $615K in Q2 2026.
SeaStar Medical Holding, Q2 2026: revenue $615K (+82% year over year), operating margin -616.4%, net loss $3.7M, operating cash flow −$3.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $615K | $338K | $277K | +82% |
| Other income, net | $61K | −$246K | $307K | — |
| Net loss | $3.7M | $2.0M | $1.7M | +86% |
| Costs & expenses | $4.4M | $2.3M | $2.1M | +88% |
| Operating costs | $4.4M | $2.1M | $2.3M | +110% |
| Cost of revenue | $54K | $27K | $27K | +100% |
| Research & development | $2.5M | $1.0M | $1.5M | +143% |
| General & admin | $1.8M | $1.0M | $802K | +78% |
| Operating cash sources | $3.7M | $1.9M | $1.8M | +96% |
| Working capital & other | $736K | −$1.1M | $1.8M | — |
| Cash used in operations | $3.0M | $3.0M | −$13K | -0.4% |
| Net loss absorbed | $3.7M | $2.0M | $1.7M | +86% |
Questions
How much did SeaStar Medical Holding's revenue grow year over year in Q2 2026?
SeaStar Medical Holding's revenue rose $277K (+82%) from $338K in Q2 2025 to $615K in Q2 2026.